Search
for
Sort by
Research 811–840 of 1000+
- Extracellular fraction of adipose tissue as an innovative regenerative approach for vitiligo treatment
- Synthesis and in Vitro Evaluation of 4-Substituted N-(1,1-Dimethylethyl)-3-oxo-4-androstene-17.beta.-carboxamides as 5.alpha.-Reductase Inhibitors and Antiandrogens
- Discovery of Natural Steroid 5 Alpha-Reductase Inhibitors
- Fibroblast heterogeneity and tertiary lymphoid tissues in the kidney
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- 5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis
- 5α-Reductase Inhibitors Do Not Prevent the Development and Progression of Urothelial Cancer: In Vitro Evidence
- RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER
- Clinical use of 5α-reductase inhibitors
- The relevance of using 5α-reductase inhibitors in the conservative management of benign prostatic hyperplasia: A review
- Novel type 1 5a-reductase Inhibitors with Antiproliferative Potential on LNCaP cells
- Evaluation of the phenotypic, proliferative and secretory profile of mesenchymal stem cells from adipose tissue captured by laser-assisted liposuction
- 5-alpha reductase inhibitors: New evidences on benefits and harms beyond benign prostatic hyperplasia
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- Role of plasminogen activator inhibitor type 1 (PAI-1) in PCOS patient
- New Activators and Inhibitors in the Hair Cycle Clock: Targeting Stem Cells’ State of Competence
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Comparison of the Therapeutic Effect of Allogeneic and Xenogeneic Small Extracellular Vesicles in Soft Tissue Repair
- Inhibitory effect of tianeptine on catagen induction in alopecia areata-like lesions induced by ultrasonic wave stress in mice
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells
- Association of long-term 5α-reductase inhibitor use with survival in men with renal cell carcinoma: a nationwide population-based cohort study
- Platelet-Therapeutics to Improve Tissue Regeneration and Wound Healing—Physiological Background and Methods of Preparation
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- Dermal White Adipose Tissue: A Newly Recognized Layer of Skin Innate Defense
- Hair growth effects of oral administration of finasteride, a steroid 5 alpha-reductase inhibitor, alone and in combination with topical minoxidil in the balding stumptail macaque.
- Persistent Erectile Dysfunction after Discontinuation of 5-Alpha Reductase Inhibitor Therapy in Rats Depending on the Duration of Treatment
- 5-Alpha-Reductase Inhibitors and Combination Therapy
- 5-Alpha Reductase Inhibitors in Prostate Cancer: From Clinical Trials to Clinical Practice
- Effects of 5-alpha reductase inhibitors